Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Umberto Vitolo

Showing results (141-150 of 212) with videos related to

Pageof 22
Sort By:
Blood|January 10, 2025
Epcoritamab plus GemOx in transplant-ineligible relapsed/refractory DLBCL: results from the EPCORE NHL-2 trialJoshua D Brody, Judit Jørgensen, David Belada, et al.
Blood Advances|October 26, 2022
Safety and efficacy of atezolizumab with rituximab and CHOP in previously untreated diffuse large B-cell lymphomaAnas Younes, John M Burke, Bruce D Cheson, et al.
Haematologica|February 24, 2018
A B-cell receptor-related gene signature predicts survival in mantle cell lymphoma: results from the Fondazione Italiana Linfomi MCL-0208 trialRiccardo Bomben, Simone Ferrero, Tiziana D'Agaro, et al.
Blood|August 29, 2012
Final results of a multicenter trial addressing role of CSF flow cytometric analysis in NHL patients at high risk for CNS disseminationGiulia Benevolo, Alessandra Stacchini, Michele Spina, et al.
Leukemia & Lymphoma|October 2, 2012
Update on the molecular pathogenesis and clinical treatment of mantle cell lymphoma: report of the 11th annual conference of the European Mantle Cell Lymphoma NetworkMartin Dreyling, Hanneke C Kluin-Nelemans, Sílvia Beà, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 8, 2011
First-line treatment for primary testicular diffuse large B-cell lymphoma with rituximab-CHOP, CNS prophylaxis, and contralateral testis irradiation: final results of an international phase II trialUmberto Vitolo, Annalisa Chiappella, Andrés J M Ferreri, et al.
European Journal of Cancer (Oxford, England : 1990)|March 25, 2017
Rituximab maintenance improves overall survival of patients with follicular lymphoma-Individual patient data meta-analysisLiat Vidal, Anat Gafter-Gvili, Gilles Salles, et al.
Leukemia & Lymphoma|August 20, 2011
Update on the molecular pathogenesis and clinical treatment of mantle cell lymphoma: report of the 10th annual conference of the European Mantle Cell Lymphoma NetworkMartin Dreyling, Hanneke C Kluin-Nelemans, Sílvia Beà, et al.
Blood|January 9, 2019
Integration of cell of origin into the clinical CNS International Prognostic Index improves CNS relapse prediction in DLBCLMagdalena Klanova, Laurie H Sehn, Isabelle Bence-Bruckler, et al.
Blood Advances|March 22, 2021
Outcomes of older patients with follicular lymphoma using individual data from 5922 patients in 18 randomized controlled trialsCarla Casulo, Jesse G Dixon, Fang-Shu Ou, et al.
Pageof 22

Showing results (141-150 of 212) with videos related to

Sort By:
Pageof 22
Blood|January 10, 2025
Epcoritamab plus GemOx in transplant-ineligible relapsed/refractory DLBCL: results from the EPCORE NHL-2 trialJoshua D Brody, Judit Jørgensen, David Belada, et al.
Blood Advances|October 26, 2022
Safety and efficacy of atezolizumab with rituximab and CHOP in previously untreated diffuse large B-cell lymphomaAnas Younes, John M Burke, Bruce D Cheson, et al.
Haematologica|February 24, 2018
A B-cell receptor-related gene signature predicts survival in mantle cell lymphoma: results from the Fondazione Italiana Linfomi MCL-0208 trialRiccardo Bomben, Simone Ferrero, Tiziana D'Agaro, et al.
Blood|August 29, 2012
Final results of a multicenter trial addressing role of CSF flow cytometric analysis in NHL patients at high risk for CNS disseminationGiulia Benevolo, Alessandra Stacchini, Michele Spina, et al.
Leukemia & Lymphoma|October 2, 2012
Update on the molecular pathogenesis and clinical treatment of mantle cell lymphoma: report of the 11th annual conference of the European Mantle Cell Lymphoma NetworkMartin Dreyling, Hanneke C Kluin-Nelemans, Sílvia Beà, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 8, 2011
First-line treatment for primary testicular diffuse large B-cell lymphoma with rituximab-CHOP, CNS prophylaxis, and contralateral testis irradiation: final results of an international phase II trialUmberto Vitolo, Annalisa Chiappella, Andrés J M Ferreri, et al.
European Journal of Cancer (Oxford, England : 1990)|March 25, 2017
Rituximab maintenance improves overall survival of patients with follicular lymphoma-Individual patient data meta-analysisLiat Vidal, Anat Gafter-Gvili, Gilles Salles, et al.
Leukemia & Lymphoma|August 20, 2011
Update on the molecular pathogenesis and clinical treatment of mantle cell lymphoma: report of the 10th annual conference of the European Mantle Cell Lymphoma NetworkMartin Dreyling, Hanneke C Kluin-Nelemans, Sílvia Beà, et al.
Blood|January 9, 2019
Integration of cell of origin into the clinical CNS International Prognostic Index improves CNS relapse prediction in DLBCLMagdalena Klanova, Laurie H Sehn, Isabelle Bence-Bruckler, et al.
Blood Advances|March 22, 2021
Outcomes of older patients with follicular lymphoma using individual data from 5922 patients in 18 randomized controlled trialsCarla Casulo, Jesse G Dixon, Fang-Shu Ou, et al.
Pageof 22